Member Info for Kevinl1977

Ries
I expect a further update via RNS prior to 23/2/23.

Otherwise, why the invite? To repeat the info they already know from the last RNS.
Make your own mind up.
GL

Viking
As per the last RNS.
‘will host a Science Day for City analysts and fund managers on 23rd February 2023 to discuss recent progress within the Company's Therapeutics Division and hear from selected key opinion leaders in the field of oncology.’
If there is nothing else to share, then why the invite?
GLA

Kenny
Your second post is almost as good as your first:
‘Evening chaps and chapettes, I keep seeing people raging on about this share and just wondered if someone can fill me in on what all the excitement is all about? looking to potentially invest as im all cash at the moment. Any timelines for expected news?’
Just saying….

Lower price top up!

At this price
DYOR

Maybe we should all put this message on every day and when we have a red day then say told you so.
Great post lick

Revoy
Don’t listen to people on here for advice.
DYOR and listen to AS in recent feedback and consult the informative RNS.
That should explain everything.
GL

More media support for our positive news.
Onwards…

Are you serious?
The SP is £1.60 and you’re asking if we would accept such a huge figure.
Of course, where do I sell for that amount?
Let me know whilst I look at a few things I am going to buy.

Every village has one….

Good post PJT.

Thorno
Agreed.

CJ
An approved product?
The product is currently in trials and has a long way to go before it is approved for use.
If safety and efficacy in a P2 trial is proven and statistically significant it will go to the pharmaceutical data companies where the health economists will decide if it’s cost effective and adds extended life to patients or hopefully more.
This will be a long term hold, as with all pharmaceutical products, unless a takeover occurs.
Feb and June 2023 are the first notable timelines from AS. These should improve the SP, imo.

Filtered

Only to the CEO, if you are a LTH.
We all appreciate other people’s opinions are going to be present, as this platform is for that very thing.
However, when the expert stated words like:
Data is unequivocal.
Delighted it is being released at significant levels.
Safety profile very positive and favourable.
Very promising.
Very encouraging.
Many will pretend to be experts on here, but only the above counts at this stage.
Next important timelines:
Science day (23/2/23)
Increased dose expansion completion (30/6/23).
Enjoy building a larger position, ready for data rich feedback in 2023 that significantly enhances the SP/takeover, etc.

RAH
Agreed, we know it works.
Sitting on your hands is very easy to do until Feb, then June for the next milestone.
Unless you need to operate any keys on the PC to purchase more, of course.
GLA

Good news but just read the recent RNS for the future outlook.
Can’t imagine many shorting this as big players build a strong position leading up to and beyond Science day..

IceC
Agreed unequivocally

Excellento -BOOM!

I will continue to build a position nice and slowly leading up to Science day.